<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46732">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01684527</url>
  </required_header>
  <id_info>
    <org_study_id>0039-12-HYMC</org_study_id>
    <nct_id>NCT01684527</nct_id>
  </id_info>
  <brief_title>Immature Myeloid Cells in Respiratory Syncytial Virus Bronchioliltis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that Respiratory Syncytial Virus (RSV) infection may influence
      the population of lung immature myeloid cells and dendritic cells in a way that will impair
      their ability to invoke an effective immune response and lead to prolonged inflammation,
      angiogenesis and scarring.  This may lead in turn to disturbed lung function.

      Our aim is to determine the presence and phenotype of immature myeloid cells present in
      respiratory secretions of children with RSV bronchiolitis as compared to non-RSV
      bronchiolitis and healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of Immature Myeloid Cells in Respiratory Secretions</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Respiratory secretions obtained from child presenting with bronchiolitis will be examined for the presence of immature myeloid cells</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">55</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Children Suffering From  Bronchiolitis</arm_group_label>
    <description>Respiratory secretions obtained from children suffering from Bronchiolitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Children</arm_group_label>
    <description>Respiratory secretions obtained from children with no respiratory infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respiratory secretions obtained</intervention_name>
    <arm_group_label>Children Suffering From  Bronchiolitis</arm_group_label>
    <arm_group_label>Healthy Children</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children presenting in our pediatric department suffering from bronchiolitis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bronchiolitis

        Exclusion Criteria:

          -  Chronic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vered Nir, MD</last_name>
      <phone>972-4-630-4331</phone>
      <email>verednr@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Vered Nir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 10, 2012</lastchanged_date>
  <firstreceived_date>September 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
